TCL Archive After 30 Years As NCI-Designated Center, Vermont Cancer Center Loses Core Grant. November 14, 2008
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive Danish Researchers Post Long-Awaited Aranesp Results–Ever So Discreetly. February 16, 2007
